Implementing and evaluating genomic screening programs in health care systems [electronic resource] : proceedings of a workshop

상세정보

자료유형	단행본
서명/저자사항	Implementing and evaluating genomic screening programs in health care systems [electronic resource]: proceedings of a workshop / Siobhan Addie, Meredith Hackmann, Theresa Wizemann, and Sarah Beachy, rapporteurs ; Roundtable on Genomics and Precision Health, Board on Health Sciences Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine.
개인저자	Addie, Siobhan, rapporteur. Hackmann, Meredith, rapporteur. Wizemann, Theresa M., rapporteur. Beachy, Sarah H., rapporteur.
단체저자명	National Academies of Sciences, Engineering, and Medicine (U.S.). Roundtable on Genomics and Precision Health,issuing body.
발행사항	Washington, DC: The National Academies Press, 2018.
형태사항	1 online resource (1 PDF file (xx, 130 pages)) : illustrations.
기타형태 저록	Print version: Addie, Siobhan. Implementing and evaluating genomic screening programs in health care systems. Washington, DC : National Academies Press, [2018] 9780309473415
ISBN	9780309473446 0309473446 9780309473422 030947342X
기타표준부호	10.17226/25048doi
일반주기	"Proceedings of a workshop"---Cover.
서지주기	Includes bibliographical references.
내용주기	Introduction -- Evidence considerations for integrating genomics-based programs into health care systems -- Financial considerations for implementing genomics-based screening programs -- Exploring approaches to optimize data sharing among early implementers of genomics-based programs -- Understanding participant needs and preferences and improving diversity and equity -- Improving health through the integration of genomics-based programs: potential next steps.
이용제한사항	Access restricted to subscribing institutions.
요약	Genomic applications are being integrated into a broad range of clinical and research activities at health care systems across the United States. This trend can be attributed to a variety of factors, including the declining cost of genome sequencing and the potential for improving health outcomes and cutting the costs of care. The goals of these genomics-based programs may be to identify individuals with clinically actionable variants as a way of preventing disease, providing diagnoses for patients with rare diseases, and advancing research on genetic contributions to health and disease. Of particular interest are genomics- based screening programs, which will, in this publication, be clinical screening programs that examine genes or variants in unselected populations in order to identify individuals who are at an increased risk for a particular health concern (e.g., diseases, adverse drug outcomes) and who might benefit from clinical interventions. On November 1, 2017, the National Academies of Sciences, Engineering, and Medicine hosted a public workshop to explore the challenges and opportunities associated with integrating genomics-based screening programs into health care systems. This workshop was developed as a way to explore the challenges and opportunities associated with integrating genomics-based programs in health care systems in the areas of evidence collection, sustainability, data sharing, infrastructure, and equity of access. This publication summarizes the presentations and discussions from the workshop.
기금정보주기	This project was supported by contracts between the National Academy of Sciences and 23andMe (unnumbered contract); Accenture (unnumbered contract); Air Force Medical Service (FA8052-17-P-0007); American Academy of Nursing (unnumbered contract); American College of Medical Genetics and Genomics (unnumbered contract); American Medical Association (unnumbered contract); American Society of Human Genetics (unnumbered contract); Association for Molecular Pathology (unnumbered contract); Biogen (unnumbered contract); Blue Cross and Blue Shield Association (unnumbered contract); College of American Pathologists (unnumbered contract); Color Genomics (unnumbered contract); Department of Veterans Affairs (Contract No. VA240-14-C-0037); Eisai Inc. (unnumbered contract); Eli Lilly and Company (unnumbered contract); Health Resources and Services Administration (HHSH250201500001I, Order No. HHSH250); Illumina, Inc. (unnumbered contract); Johnson & Johnson (unnumbered contract); Marc Grodman (unnumbered contract); Merck & Co., Inc. (Contract No. CMO-170216-001875); National Institutes of Health (Contract No. HHSN263201200074I; Task Order No. HHSN 26300093): National Cancer Institute; National Human Genome Research Institute; National Institute of Mental Health; National Institute of Nursing Research; National Institute on Aging; and Office of Disease Prevention; National Society of Genetic Counselors (unnumbered contract); and Northrop Grumman Health IT (unnumbered contract). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
회의명	Implementing and Evaluating Genomic Screening Programs in Health Care Systems (Workshop) (2017 : Washington, D.C.)
일반주제명	Genetic Testing. Mass Screening. Genomics. Genetic Predisposition to Disease. Human chromosome abnormalities --Diagnosis --United States --Congresses. Genetic screening --United States --Congresses. Genomics --United States --Congresses. Genetic disorders --United States --Congresses. Medical care --United States --Congresses. SCIENCE / Life Sciences / Biochemistry. Genomics. Human chromosome abnormalities --Diagnosis.
분류기호(NLMC)	2018 G-407 QZ 52
분류기호(DDC)	572.865
언어	영어
바로가기